期刊
ONCOTARGET
卷 1, 期 1, 页码 69-76出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.110
关键词
-
资金
- NIH [T32-CA009054]
- University of California
- Intellikine, Inc.
- Jackie Murphy and Carol Malouf Scholar Achievement Rewards for College Scientists
A challenge in cancer therapy has been to identify targets whose function is essential for survival of malignant cells but not normal cells. This Perspective discusses recent evidence that novel inhibitors of the kinase TOR can provide an unprecedented balance of anti-cancer efficacy and tolerability.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
